← Back to all stories
Vitamin D Compound Shows Promise in Weakening Pancreatic Cancer's Defenses
Photo: Steve A Johnson / Unsplash
A small clinical trial has found that a vitamin D analog can help break down the protective barrier surrounding pancreatic cancer tumors. This breakthrough potentially makes the cancer much more vulnerable to chemotherapy and immunotherapy, with especially encouraging results in patients with high levels of vitamin D receptors.
A small clinical trial has found that a vitamin D analog can help break down the protective barrier surrounding pancreatic cancer tumors. This breakthrough potentially makes the cancer much more vulnerable to chemotherapy and immunotherapy, with especially encouraging results in patients with high levels of vitamin D receptors.